Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Prehypertension is not associated with all-cause mortality: a systematic review and meta-analysis of prospective studies.

Guo X, Zhang X, Zheng L, Guo L, Li Z, Yu S, Yang H, Zhou X, Zou L, Zhang X, Sun Z, Li J, Sun Y.

PLoS One. 2013 Apr 25;8(4):e61796. doi: 10.1371/journal.pone.0061796. Print 2013. Review.

2.

Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies.

Guo X, Zhang X, Guo L, Li Z, Zheng L, Yu S, Yang H, Zhou X, Zhang X, Sun Z, Li J, Sun Y.

Curr Hypertens Rep. 2013 Dec;15(6):703-16. Review.

PMID:
24234576
3.

Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis.

Huang Y, Su L, Cai X, Mai W, Wang S, Hu Y, Wu Y, Tang H, Xu D.

Am Heart J. 2014 Feb;167(2):160-168.e1. doi: 10.1016/j.ahj.2013.10.023. Epub 2013 Nov 6. Review.

PMID:
24439976
4.

Prehypertension and incidence of cardiovascular disease: a meta-analysis.

Huang Y, Wang S, Cai X, Mai W, Hu Y, Tang H, Xu D.

BMC Med. 2013 Aug 2;11:177. doi: 10.1186/1741-7015-11-177.

5.

Prehypertension and the risk of stroke: a meta-analysis.

Huang Y, Cai X, Li Y, Su L, Mai W, Wang S, Hu Y, Wu Y, Xu D.

Neurology. 2014 Apr 1;82(13):1153-61. doi: 10.1212/WNL.0000000000000268. Epub 2014 Mar 12.

PMID:
24623843
6.

Prehypertension and Incidence of ESRD: a systematic review and meta-analysis.

Huang Y, Cai X, Zhang J, Mai W, Wang S, Hu Y, Ren H, Xu D.

Am J Kidney Dis. 2014 Jan;63(1):76-83. doi: 10.1053/j.ajkd.2013.07.024. Epub 2013 Sep 26.

PMID:
24074825
7.

Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease.

Shen L, Ma H, Xiang MX, Wang JA.

Am J Cardiol. 2013 Jul 15;112(2):266-71. doi: 10.1016/j.amjcard.2013.03.023. Epub 2013 Apr 19.

PMID:
23608614
8.

Presence of baseline prehypertension and risk of incident stroke: a meta-analysis.

Lee M, Saver JL, Chang B, Chang KH, Hao Q, Ovbiagele B.

Neurology. 2011 Oct 4;77(14):1330-7. doi: 10.1212/WNL.0b013e3182315234. Epub 2011 Sep 28.

9.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
10.

Ursodeoxycholic acid for primary biliary cirrhosis.

Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD000551. doi: 10.1002/14651858.CD000551.pub3. Review.

PMID:
23235576
11.

Hypertension and Prehypertension and Prediction of Development of Decreased Estimated GFR in the General Population: A Meta-analysis of Cohort Studies.

Garofalo C, Borrelli S, Pacilio M, Minutolo R, Chiodini P, De Nicola L, Conte G.

Am J Kidney Dis. 2016 Jan;67(1):89-97. doi: 10.1053/j.ajkd.2015.08.027. Epub 2015 Oct 23. Review.

PMID:
26475392
12.

Low-carbohydrate diets and all-cause mortality: a systematic review and meta-analysis of observational studies.

Noto H, Goto A, Tsujimoto T, Noda M.

PLoS One. 2013;8(1):e55030. doi: 10.1371/journal.pone.0055030. Epub 2013 Jan 25. Review.

13.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
14.

Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008521. doi: 10.1002/14651858.CD008521.pub3. Review.

PMID:
23152260
15.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

16.

Impact of lower range of prehypertension on cardiovascular events in a general population: the Hisayama Study.

Fukuhara M, Arima H, Ninomiya T, Hata J, Yonemoto K, Doi Y, Hirakawa Y, Matsumura K, Kitazono T, Kiyohara Y.

J Hypertens. 2012 May;30(5):893-900. doi: 10.1097/HJH.0b013e328351d380.

PMID:
22388232
17.

Combined effect of high-normal blood pressure and low HDL cholesterol on mortality in an elderly Korean population: the South-West Seoul (SWS) study.

Kim NH, Cho HJ, Kim YJ, Cho MJ, Choi HY, Eun CR, Kim JH, Yang SJ, Yoo HJ, Kim HY, Seo JA, Kim SG, Baik SH, Choi DS, Choi KM.

Am J Hypertens. 2011 Aug;24(8):918-23. doi: 10.1038/ajh.2011.78. Epub 2011 Apr 28.

PMID:
21525969
18.

Prehypertension and risk of cardiovascular disease in Chinese adults.

Gu D, Chen J, Wu X, Duan X, Jones DW, Huang JF, Chen CS, Chen JC, Kelly TN, Whelton PK, He J.

J Hypertens. 2009 Apr;27(4):721-9. doi: 10.1097/HJH.0b013e328323ad89.

PMID:
19300109
19.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
20.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900

Supplemental Content

Support Center